Natus Medical Inc
NASDAQ:NTUS
Natus Medical Inc
Revenue
Natus Medical Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Natus Medical Inc
NASDAQ:NTUS
|
Revenue
$473.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Natus Medical Inc
Revenue Breakdown
Breakdown by Geography
Natus Medical Inc
Total Revenue:
473.4m
USD
|
United States:
286m
USD
|
Non-Us:
187.5m
USD
|
Breakdown by Segments
Natus Medical Inc
Total Revenue:
473.4m
USD
|
Neurology Products:
284.8m
USD
|
Newborn Care Products:
105m
USD
|
Otometricsproducts:
83.6m
USD
|
See Also
What is Natus Medical Inc's Revenue?
Revenue
473.4m
USD
Based on the financial report for Dec 31, 2021, Natus Medical Inc's Revenue amounts to 473.4m USD.
What is Natus Medical Inc's Revenue growth rate?
Revenue CAGR 5Y
4%
Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Natus Medical Inc have been -4% over the past three years , 4% over the past five years .